retatrutide clinical trial weight loss results Medscape | Retatrutide, Eli Lilly's first-in-class triple hormone receptor agonist, delivered meaningful at 80 weeks in all doses in the Phase III retatrutide study demonstrates

I wonder what would have happened if I was actually able to lose the extra weight that I needed to lose, even though I had done everything that I could

For example, in the STEP 1 (Semaglutide Treatment Effect in People with Obesity) trial, all participants received individual counseling every four weeks to support adherence to a reduced-calorie diet (500 kcal/day deficit from estimated energy expenditure) and to encourage at least 150 minutes per week of physical activity, such as walking

These are identical formulations that could be priced to compete with generics, though no pricing has been announced yet

But the real GLP-1 story appears to be just getting started

Cardiovascular and Renal Outcomes With Efpeglenatide in Type 2 Diabetes

To understand tirzepatide-specific timing, how fast tirzepatide works covers the pharmacokinetic details, and how long it takes for tirzepatide to work addresses onset expectations